深夜，大涨！美国退休金突发！

Group 1: 401K Retirement Savings Plan Changes - The U.S. President Trump is set to sign an executive order allowing alternative assets such as private equity, real estate, and cryptocurrencies to be included in 401K retirement savings plans, potentially opening up approximately $12.5 trillion in retirement account funds to these sectors [2][3] - The executive order will instruct the Department of Labor to reassess the investment guidelines for alternative assets in retirement plans as per the Employee Retirement Income Security Act of 1974 [2][3] - The SEC will be tasked with facilitating alternative asset investments for participant-directed retirement plans, marking a significant move to integrate private assets into fixed contribution accounts [3] Group 2: Eli Lilly's Weight Loss Drug Performance - Eli Lilly reported second-quarter earnings that exceeded market expectations, with revenue of $15.557 billion, a 38% year-over-year increase, and net income of $5.661 billion, a 91% increase [5] - Despite strong earnings, the company's stock plummeted by 13% due to disappointing results from its experimental weight loss drug orforglipron, which helped patients lose about 11% of their weight, falling short of market expectations [5] - Analysts suggest that the underperformance of orforglipron may lead investors to reassess the competitive landscape of GLP-1 obesity drugs, potentially benefiting Novo Nordisk's oral semaglutide [5] Group 3: Intel CEO Controversy - President Trump called for Intel CEO Pat Gelsinger to resign, citing serious conflicts of interest, although no specific reasons were provided [6] - Following the announcement, Intel's stock fell by over 2% [6] - Intel stated that it values its role in U.S. national security and will communicate with relevant parties regarding the concerns raised [6]